Amy C Degnim

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc Breast cancer presenting as unilateral arm edema
    Shaheen Zakaria
    Department of Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Gen Intern Med 22:675-6. 2007
  2. ncbi request reprint Immune cell quantitation in normal breast tissue lobules with and without lobulitis
    Amy C Degnim
    Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
    Breast Cancer Res Treat 144:539-49. 2014
  3. doi request reprint Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations
    Amy C Degnim
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Ann Surg 258:240-7. 2013
  4. ncbi request reprint Surgical site infection after breast surgery: impact of 2010 CDC reporting guidelines
    Amy C Degnim
    Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA
    Ann Surg Oncol 19:4099-103. 2012
  5. ncbi request reprint A prospective study of breast lymphedema: frequency, symptoms, and quality of life
    Amy C Degnim
    Department of Surgery, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Breast Cancer Res Treat 134:915-22. 2012
  6. pmc Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues
    Amy C Degnim
    Department of Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Breast Cancer Res Treat 133:169-77. 2012
  7. pmc Diagnostic utility of snail in metaplastic breast carcinoma
    Aziza Nassar
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Diagn Pathol 5:76. 2010
  8. pmc Pseudoangiomatous stromal hyperplasia and breast cancer risk
    Amy C Degnim
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 17:3269-77. 2010
  9. ncbi request reprint Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients
    Amy C Degnim
    Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA
    Cancer 98:2307-15. 2003
  10. doi request reprint Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)]
    Amy C Degnim
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 17:2685-9. 2010

Detail Information

Publications79

  1. pmc Breast cancer presenting as unilateral arm edema
    Shaheen Zakaria
    Department of Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Gen Intern Med 22:675-6. 2007
    ..Symptomatic arm lymphedema as the presenting symptom of invasive breast carcinoma is a rare occurrence...
  2. ncbi request reprint Immune cell quantitation in normal breast tissue lobules with and without lobulitis
    Amy C Degnim
    Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA
    Breast Cancer Res Treat 144:539-49. 2014
    ..Lobules with lobulitis have significantly more adaptive immune (B and T) cells, but no increase in dendritic cells or monocytes/macrophages. These findings indicate an active and dynamic mucosal immune system in normal breast tissue. ..
  3. doi request reprint Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations
    Amy C Degnim
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Ann Surg 258:240-7. 2013
    ..To determine whether bacterial colonization of drains can be reduced by local antiseptic interventions...
  4. ncbi request reprint Surgical site infection after breast surgery: impact of 2010 CDC reporting guidelines
    Amy C Degnim
    Department of Surgery, Mayo Clinic College of Medicine, Rochester, MN, USA
    Ann Surg Oncol 19:4099-103. 2012
    ....
  5. ncbi request reprint A prospective study of breast lymphedema: frequency, symptoms, and quality of life
    Amy C Degnim
    Department of Surgery, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905, USA
    Breast Cancer Res Treat 134:915-22. 2012
    ..The condition is characterized by diffuse skin edema and erythema as well as self-reported symptoms with a low level of distress...
  6. pmc Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues
    Amy C Degnim
    Department of Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Breast Cancer Res Treat 133:169-77. 2012
    ..Breast tissue samples from normal donors represent a unique tissue resource with histologic features consistent with lower breast cancer risk...
  7. pmc Diagnostic utility of snail in metaplastic breast carcinoma
    Aziza Nassar
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Diagn Pathol 5:76. 2010
    ..and overall survival. A combination of p63, OSCAR and WS-KER are useful in its work-up. On the other hand, Snail is neither a diagnostic nor a prognostic marker for MBC...
  8. pmc Pseudoangiomatous stromal hyperplasia and breast cancer risk
    Amy C Degnim
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 17:3269-77. 2010
    ..Pseudoangiomatous stromal hyperplasia (PASH) is a benign localized fibrotic lesion in which clusters of spindle cells form cleftlike spaces, resembling ectatic vessels. Its relationship to breast cancer risk has not been characterized...
  9. ncbi request reprint Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients
    Amy C Degnim
    Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA
    Cancer 98:2307-15. 2003
    ....
  10. doi request reprint Axillary recurrence in breast cancer patients with isolated tumor cells in the sentinel lymph node [AJCC N0(i+)]
    Amy C Degnim
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 17:2685-9. 2010
    ..2 mm [N0(i+)]. Our goal was to characterize patients with SLN isolated tumor cells regarding surgical management and axillary recurrence...
  11. ncbi request reprint Sentinel lymph node biopsy for breast cancer: is two-site injection best?
    Amy C Degnim
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Surgery 139:630-2. 2006
  12. ncbi request reprint Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram
    Amy C Degnim
    Department of Surgery, Mayo Clinic, 200 First St, SW, Rochester, MN 55905, USA
    Am J Surg 190:543-50. 2005
    ..The accurate prediction of nonsentinel node (NSN) metastasis in breast cancer patients remains uncertain...
  13. ncbi request reprint Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
    Amy C Degnim
    Division of Surgical Oncology, University of Michigan Health System, 1500 E Medical Center Drive, 3308 CGC Box 0932, Ann Arbor, Michigan, 48109, USA
    Ann Surg Oncol 12:712-7. 2005
    ..We hypothesized that blue dye could be safely omitted in the subgroup of patients who have evidence of successful sentinel node localization by lymphoscintigraphy...
  14. pmc Novel breast tissue feature strongly associated with risk of breast cancer
    Kevin P McKian
    Department of Oncology, Mayo Clinic Cancer Center, Mayo Graduate School of Medical Education, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Oncol 27:5893-8. 2009
    ..Breast lobules are the anatomic sites of origin of breast cancer. As women age, these lobular structures should regress, which results in reduced breast cancer risk. However, this does not occur in all women...
  15. ncbi request reprint Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node
    Aeisha K Rivers
    Department of Surgery, St Joseph s Hospital and Medical Center, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, Michigan, 48109, USA
    Ann Surg Oncol 13:36-44. 2006
    ..Our goal was evaluate clinicopathologic features that might serve as surrogates for determining which patients with a positive SLN are likely or unlikely to belong to this high-risk subset...
  16. pmc Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer
    Fritcher Emily G Barr
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Cancer Prev Res (Phila) 4:435-44. 2011
    ..We found increasing ER expression in AH with increasing age. ER expression in AH does not further discriminate breast cancer risk in women with atypia...
  17. pmc Assessment of the accuracy of the Gail model in women with atypical hyperplasia
    V Shane Pankratz
    Division of Biostatistics, Medical Oncology, General Surgery, Internal Medicine, Epidemiology, and Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
    J Clin Oncol 26:5374-9. 2008
    ..Women with biopsy-confirmed atypical hyperplasia of the breast (atypia) are at high risk for breast cancer. The Gail model is widely used in these women, but has not been validated in them...
  18. pmc Evaluation of the Tyrer-Cuzick (International Breast Cancer Intervention Study) model for breast cancer risk prediction in women with atypical hyperplasia
    Judy C Boughey
    Mayo Clinic, Rochester, MN 55905, USA
    J Clin Oncol 28:3591-6. 2010
    ..We evaluated the performance of the Tyrer-Cuzick model, which was designed to predict 10-year risk of breast cancer development, in a well-defined cohort of women with atypia...
  19. doi request reprint Current status of radioactive seed for localization of non palpable breast lesions
    James W Jakub
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Am J Surg 199:522-8. 2010
    ..This review highlights the literature regarding RSL, including safety, the ease of the procedure, billing, and oncologic outcomes...
  20. ncbi request reprint National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast procedures requiring drains: survey of the American Society of Breast Surgeons
    Rushin D Brahmbhatt
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 19:3205-11. 2012
    ..To assess national practice patterns regarding use of perioperative antibiotics by surgeons performing breast operations requiring drainage tubes...
  21. doi request reprint Quality of life after breast cancer surgery: What have we learned and where should we go next?
    Barbara A Pockaj
    Division of General Surgery, Mayo Clinic, 5777 East Mayo Boulevard, Phoenix, AZ 85054, USA
    J Surg Oncol 99:447-55. 2009
    ..Although multiple studies have evaluated breast surgery quality-of-life outcomes, the data are inconsistent. This factor is important to consider when counseling patients and defining surgical quality measures...
  22. doi request reprint Should axillary ultrasound be used in patients with a preoperative diagnosis of ductal carcinoma in situ?
    Bijan Ansari
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Am J Surg 204:290-3. 2012
    ..We evaluated the usefulness of axillary ultrasound (US) in patients with core biopsy-proven ductal carcinoma in situ (DCIS)...
  23. doi request reprint Breast cancer risk in women with radial scars in benign breast biopsies
    Jena C Berg
    Department of Laboratory Medicine and Pathology, Division of Anatomic Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Breast Cancer Res Treat 108:167-74. 2008
    ..We studied the relative risk of radial scar lesions in a large cohort of patients with benign breast disease (BBD)...
  24. doi request reprint Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factors
    Judy C Boughey
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA
    Cancer 116:3322-9. 2010
    ..The objective of the current study was to investigate the factors affecting the number of AxLNs identified at ALND...
  25. doi request reprint Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?
    Shaheen Zakaria
    Department of Surgery, Mayo Clinic, Rochester, Minn 55905, USA
    Surgery 143:641-7. 2008
    ..This study was designed to assess locoregional recurrence in patients with positive SNs who did not undergo CALND...
  26. ncbi request reprint Stratification of breast cancer risk in women with atypia: a Mayo cohort study
    Amy C Degnim
    Division of General Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Oncol 25:2671-7. 2007
    ..Atypical hyperplasia is a well-recognized risk factor for breast cancer, conveying an approximately four-fold increased risk. Data regarding long-term absolute risk and factors for risk stratification are needed...
  27. ncbi request reprint Age-related lobular involution and risk of breast cancer
    Tia R Milanese
    Mayo Medical School, Rochester, MN 55905, USA
    J Natl Cancer Inst 98:1600-7. 2006
    ..As women age, the lobules in their breasts undergo involution or regression. We investigated whether lobular involution in women with benign breast disease was associated with subsequent breast cancer risk...
  28. doi request reprint A positive intramammary lymph node does not mandate a complete axillary node dissection
    Ricardo Diaz
    Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg 203:151-5. 2012
    ..We hypothesized that even in the face of a positive intramammary lymph node (IMLN) a negative axillary sentinel lymph node (SLN) reliably stages the axilla and complete axillary lymph node dissection (CALND) can be avoided...
  29. doi request reprint Distance of breast cancer from the skin and nipple impacts axillary nodal metastases
    Bijan Ansari
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 18:3174-80. 2011
    ..The aim of this study was to determine whether distance of breast cancers from the skin and/or distance from the nipple impacts the likelihood of axillary nodal metastases...
  30. ncbi request reprint A multidisciplinary approach to the management of breast cancer, part 1: prevention and diagnosis
    Sandhya Pruthi
    Division of General Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Mayo Clin Proc 82:999-1012. 2007
    ....
  31. doi request reprint Intramammary lymph nodes: patterns of discovery and clinical significance
    Sandeep S Vijan
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN 55901, USA
    Surgery 145:495-9. 2009
    ..We sought to determine how often axillary node metastases were present in patients with intramammary lymph node (IMLN) metastasis and if the method of IMLN discovery impacts likelihood of axillary node metastasis...
  32. doi request reprint The number of axillary lymph nodes involved with metastatic breast cancer does not affect outcome as long as all disease is confined to the sentinel lymph nodes
    James W Jakub
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN, USA
    Ann Surg Oncol 18:86-93. 2011
    ..This study was undertaken to determine whether metastatic disease confined to the sentinel lymph nodes (SLN) has better prognosis than metastatic disease spread to non-SLNs, regardless of the number of nodes involved...
  33. ncbi request reprint Efficacy of sentinel lymph node biopsy in male breast cancer
    Vincent M Cimmino
    Division of Surgical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109 0932, USA
    J Surg Oncol 86:74-7. 2004
    ..SLNB has been championed as a procedure aimed at preventing those morbidities. We recently have evaluated the role of SLNB in the treatment of men with early stage breast cancer...
  34. doi request reprint Contralateral prophylactic mastectomy: long-term consistency of satisfaction and adverse effects and the significance of informed decision-making, quality of life, and personality traits
    Marlene H Frost
    Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 18:3110-6. 2011
    ....
  35. doi request reprint Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
    Carol Reynolds
    Department of Pathology, Mayo Clinic, Division of Anatomic Pathology, Rochester, MN, USA
    Ann Surg Oncol 18:3102-9. 2011
    ..Use of nipple-sparing mastectomy (NSM) is increasing. We sought to look at the role of NSM in BRCA mutation carriers...
  36. pmc Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging
    Rajini Katipamula
    Department of Oncology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    J Clin Oncol 27:4082-8. 2009
    ..We sought to analyze the trends in mastectomy rates and the relationship to preoperative MRI and surgical year at Mayo Clinic, Rochester, MN...
  37. doi request reprint Complications associated with postoperative antibiotic prophylaxis after breast surgery
    Alyssa D Throckmorton
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Am J Surg 198:553-6. 2009
    ..Evidence supports single-dose preoperative antibiotic (ABX) prophylaxis for breast surgery; however, limited data exist regarding the incidence and type of antibiotic complications postoperatively...
  38. doi request reprint Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients
    Jeffrey S Scow
    Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA
    Cancer 115:4064-70. 2009
    ..They compared it with the Mayo and Memorial Sloan-Kettering Cancer Center (MSKCC) nomograms...
  39. doi request reprint Postoperative prophylactic antibiotics and surgical site infection rates in breast surgery patients
    Alyssa D Throckmorton
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 16:2464-9. 2009
    ..Some surgeons also prescribe postoperative prophylaxis for all patients with drains to prevent infection despite its lack of proven efficacy...
  40. doi request reprint Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age
    Randy C Miles
    Mayo Medical School, Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 19:1153-9. 2012
    ..Local recurrence (LR) after breast conservation surgery (BCS) varies with risk factors. This study was designed to evaluate the impact of young age on LR...
  41. doi request reprint Simple prediction models for breast cancer patients with solitary positive sentinel nodes--are they valid?
    Jeffrey S Scow
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Breast J 15:610-4. 2009
    ..19). In our cohort, neither model accurately predicted which patients have a < or = 5% chance of having nonsentinel metastases. These models are not adequate to identify patients in whom axillary dissection can be omitted...
  42. pmc Lobular involution: localized phenomenon or field effect?
    Robert A Vierkant
    Mayo Clinic Cancer Center, Rochester, MN, USA
    Breast Cancer Res Treat 117:193-6. 2009
    ..75, 95% CI 0.59, 0.89). Our study suggests that lobular involution is a homogeneous process, supporting the use of involution measures from a single benign biopsy as a component in breast cancer risk assessment paradigms...
  43. doi request reprint Predicting four or more metastatic axillary lymph nodes in patients with sentinel node-positive breast cancer: assessment of existent risk scores
    Benjamin Zendejas
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 17:2884-91. 2010
    ..Risk prediction models designed to identify such patients have been published by Rivers et al., Chagpar et al., and Katz et al. We sought to evaluate and compare the performance of these models in an independent patient population...
  44. doi request reprint Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer
    Judy C Boughey
    Department of Surgery, Mayo Clinic College of Medicine, Mayo Clinic Cancer Center, 200 First Street, SW, Rochester, MN, USA
    Ann Surg Oncol 17:2702-9. 2010
    ..The aim of this study was to investigate whether contralateral prophylactic mastectomy (CPM) in addition to therapeutic mastectomy (TM) is associated with a survival advantage in high-risk women with breast cancer...
  45. doi request reprint Pure tubular carcinoma and axillary nodal metastases
    Martin G Fedko
    Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Ann Surg Oncol 17:338-42. 2010
    ..Pure tubular carcinoma of the breast is a rare subtype with a low incidence of axillary lymph node metastases. The aim of this study was to determine the frequency of axillary lymph node metastasis in patients with pure tubular carcinoma...
  46. ncbi request reprint Benign breast disease and the risk of breast cancer
    Lynn C Hartmann
    Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    N Engl J Med 353:229-37. 2005
    ..Benign breast disease is an important risk factor for breast cancer. We studied a large group of women with benign breast disease to obtain reliable estimates of this risk...
  47. ncbi request reprint Impact of analysis of frozen-section margin on reoperation rates in women undergoing lumpectomy for breast cancer: Evaluation of the National Surgical Quality Improvement Program data
    Judy C Boughey
    Department of Surgery, Mayo Clinic, Rochester, MN Electronic address
    Surgery 156:190-7. 2014
    ..The aim of this study was to compare reoperation rates between an institution using routine FS analysis of all margins and the National Surgical Quality Improvement Program (NSQIP) data...
  48. doi request reprint Surgical management of high-risk breast lesions
    Amy C Degnim
    Department of Surgery, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    Surg Clin North Am 93:329-40. 2013
    ....
  49. ncbi request reprint Sentinel lymph node biopsy for breast cancer: how many nodes are enough?
    Shaheen Zakaria
    Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA
    J Surg Oncol 96:554-9. 2007
    ..Sentinel lymph node (SLN) biopsy using blue dye and radioisotope often results in the removal of multiple SLNs. We sought to determine whether there is a point where the surgeon can terminate the procedure without sacrificing accuracy...
  50. ncbi request reprint Paget's disease of the breast: accuracy of preoperative assessment
    Shaheen Zakaria
    Department of General Surgery, Mayo Clinic, Rochester, MN 55905, USA
    Breast Cancer Res Treat 102:137-42. 2007
    ..We performed this study to correlate findings on clinical examination and mammography with pathologic results and outcomes in women with PD...
  51. pmc Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look?
    Barbara A Pockaj
    Department of Surgery, Mayo Clinic, Scottsdale, AZ, USA
    Ann Surg Oncol 17:2419-26. 2010
    ..It is time to conduct a carefully designed randomized trial to see whether surgery in stage IV breast cancer does indeed warrant a second look...
  52. ncbi request reprint Risk factors associated with breast lymphedema
    Judy C Boughey
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 21:1202-8. 2014
    ..The development of breast lymphedema (BLE) after breast/axillary surgery is poorly characterized. We prospectively evaluated clinical and surgical factors associated with development of BLE...
  53. ncbi request reprint Sclerosing adenosis and risk of breast cancer
    Daniel W Visscher
    Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
    Breast Cancer Res Treat 144:205-12. 2014
    ..Its role in breast carcinogenesis remains undefined; its presence may aid in risk prediction for women after a breast biopsy...
  54. doi request reprint Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience
    Jeffrey S Scow
    Department of Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Surg Oncol 101:401-7. 2010
    ..Angiosarcoma of the breast can be divided into primary and secondary. The objective was to determine clinicopathologic factors associated with breast angiosarcoma and to compare primary versus secondary angiosarcoma...
  55. doi request reprint Invasive micropapillary carcinoma of the breast: imaging features with clinical and pathologic correlation
    Katie N Jones
    Department of Radiology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    AJR Am J Roentgenol 200:689-95. 2013
    ..The purpose of this article is to present imaging findings of invasive ductal carcinoma with micropapillary features with clinical and pathologic correlation...
  56. ncbi request reprint A single-center experience with inflammatory breast cancer, 1985-2003
    Rory L Smoot
    Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Arch Surg 141:567-72; discussion 572-3. 2006
    ..quot;Up-front" surgery improves survival in inflammatory breast cancer (IBC)...
  57. pmc Cost modeling of preoperative axillary ultrasound and fine-needle aspiration to guide surgery for invasive breast cancer
    Judy C Boughey
    Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA
    Ann Surg Oncol 17:953-8. 2010
    ..We compared the costs with preoperative US/FNA to without US/FNA (standard of care) for invasive breast cancer...
  58. pmc Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer
    Benjamin Zendejas
    Department of Surgery, Mayo Clinic, 200 First St SW, Rochester MN, USA
    J Clin Oncol 29:2993-3000. 2011
    ..Current scrutiny of the medical costs led us to evaluate the cost-effectiveness of CPM versus routine surveillance as an alternative contralateral breast cancer (CBC) risk management strategy...
  59. doi request reprint Microbiology of surgical site infections complicating breast surgery
    Alyssa D Throckmorton
    Department of Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA
    Surg Infect (Larchmt) 11:355-9. 2010
    ..The aim of this study was to evaluate the results of bacterial cultures of breast SSI sites and antibiotic susceptibility testing to determine the clinical utility of these findings...
  60. ncbi request reprint Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study
    Lynn C Hartmann
    Mayo Clinic, 200 First Street SW, Rochester, MN 55905
    Cancer Prev Res (Phila) 7:211-7. 2014
    ..The ipsilateral breast is at especially high risk for breast cancer in the first 5 years after atypia, with risk remaining elevated in both breasts long term. ADH and ALH behave similarly in terms of later breast cancer endpoints...
  61. ncbi request reprint Balancing venous thromboembolism and hematoma after breast surgery
    Jenna K Lovely
    Hospital Pharmacy Services, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 19:3230-5. 2012
    ....
  62. doi request reprint Nipple-sparing mastectomy--initial experience at a tertiary center
    Nicole Sookhan
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Am J Surg 196:575-7. 2008
    ..We evaluated our initial experience with NSM in terms of clinical outcomes...
  63. doi request reprint Effect of massage therapy for postsurgical mastectomy recipients
    Nancy L Drackley
    Complementary and Integrative Medicine Program, Mayo Clinic in Rochester, MN, USA
    Clin J Oncol Nurs 16:121-4. 2012
    ..Oncology nurses should consider the feasibility of massage therapy as a valuable nonpharmcologic pain management strategy...
  64. doi request reprint Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer
    Shaheen Zakaria
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN, USA
    Am J Surg 196:228-33. 2008
    ..We aimed to evaluate the safety and efficacy of methylene blue dye (MBD) for sentinel lymph node (SLN) mapping in breast cancer...
  65. doi request reprint Pharmacokinetics of methylene blue dye for lymphatic mapping in breast cancer-implications for use in pregnancy
    Sandhya Pruthi
    Department of Internal Medicine, Breast Diagnostic Clinic, Mayo Clinic and Mayo Foundation, Rochester, MN, USA
    Am J Surg 201:70-5. 2011
    ..although blue dye is routinely used for lymphatic mapping, it is not used for lymphatic mapping in pregnancy-associated breast cancer, because of concern of fetal risk...
  66. doi request reprint Palpable presentation of breast cancer persists in the era of screening mammography
    Kellie L Mathis
    Department of Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN, USA
    J Am Coll Surg 210:314-8. 2010
    ..The aim was to describe cancer detection method and frequency of screening mammography in women undergoing breast cancer surgery in 2000...
  67. pmc Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer
    Magdalena A Cichon
    Department of Cancer Biology, Mayo Clinic, Jacksonville, FL 32224, USA
    J Mammary Gland Biol Neoplasia 15:389-97. 2010
    ..We also suggest approaches to identify processes that control earlier stages of disease progression...
  68. doi request reprint Sclerotherapy for the treatment of postmastectomy seroma
    Alyssa D Throckmorton
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Am J Surg 196:541-4. 2008
    ..Seroma is a common complication after mastectomy. We review our experience with sclerotherapy for postmastectomy seroma management...
  69. ncbi request reprint Prophylactic mastectomy
    Shaheen Zakaria
    Department of Surgery, Mayo Clinic and Mayo Foundation, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Surg Clin North Am 87:317-31, viii. 2007
    ..This article describes the high-risk women in whom PM may be considered, and summarizes data on the efficacy of PM as a treatment for the prevention of breast cancer...
  70. doi request reprint Patients' perceptions of breast MRI: a single-center study
    Shaheen Zakaria
    Department of Surgery, The Chrysalis, Rancho Mirage, CA, USA
    AJR Am J Roentgenol 192:1149-54. 2009
    ..However, patients' perceptions of breast MRI are unknown. The aim of this study was to determine patients' perception of the impact of breast MRI on their care and to compare patients' perception with objective assessments...
  71. doi request reprint A multi-site validation trial of radioactive seed localization as an alternative to wire localization
    Jenevieve H Hughes
    Department of Surgery, Mayo Clinic, Scottsdale, Arizona 85259, USA
    Breast J 14:153-7. 2008
    ..015). RSL is safe, effective, and compared to WL, reduces the rates of intraoperative re-excision and reoperation for positive margins by 68%. Patient satisfaction is improved with RSL. We strongly favor RSL over WL...
  72. ncbi request reprint A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations
    Sandhya Pruthi
    Division of General Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Mayo Clin Proc 82:1131-40. 2007
    ..The goal of this article is to provide clinicians who care for women with breast cancer a multidisciplinary, state-of-the art approach to the treatment of these patients...
  73. doi request reprint Cost-effectiveness analysis of routine frozen-section analysis of breast margins compared with reoperation for positive margins
    John B Osborn
    Department of Surgery, Mayo Clinic, Rochester, MN, USA
    Ann Surg Oncol 18:3204-9. 2011
    ..At our institution we routinely use frozen-section analysis of all margins to minimize rates of 2nd operations. The aim of this study was to evaluate the cost/benefit of routine frozen-section analysis...
  74. pmc Scientific Impact Recognition Award: Molecular breast imaging: a review of the Mayo Clinic experience
    Carrie B Hruska
    Department of Nuclear Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Am J Surg 196:470-6. 2008
    ..Molecular breast imaging (MBI) depicts functional uptake of targeted radiotracers in the breast using dedicated gamma cameras...
  75. ncbi request reprint Predictive value of sonographic features of extranodal extension in axillary lymph nodes
    Paige N Misselt
    Department of Radiology, Mayo Clinic, Rochester, MN 55905 USA
    J Ultrasound Med 29:1705-9. 2010
    ..The purpose of this study was to assess the accuracy of 5 sonographic features in the prediction of extranodal extension (ENE) in axillary lymph nodes (ALNs) of patients with biopsy-proven breast cancer...
  76. doi request reprint Value of massage therapy for patients in a breast clinic
    Sandhya Pruthi
    Division of General Internal Medicine and the Breast Clinic, Mayo Clinic, Rochester, MN, USA
    Clin J Oncol Nurs 13:422-5. 2009
    ..Although this study was small, the findings show that massage therapy may help patients with breast disease relax and feel better overall...
  77. ncbi request reprint BIS monitor findings during self-hypnosis
    Christopher M Burkle
    Department of Anesthesiology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    J Clin Monit Comput 19:391-3. 2005
    ..We describe BIS values for a patient undergoing breast surgery under self-hypnosis in order to access the value of global surface EEG measures occurring during this process...
  78. doi request reprint Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node
    Elizabeth A Mittendorf
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Ann Surg 255:109-15. 2012
    ..The goal of this study was to construct a nomogram incorporating SLN metastasis size to accurately predict non-SLN involvement in patients with SLN-positive disease...
  79. doi request reprint Appendicitis after appendectomy
    Mark J Truty
    Department of Surgery, Mayo Clinic College of Medicine, 200 First St SW, Mayo West 12, Rochester, MN 55905, USA
    Arch Surg 143:413-5. 2008
    ..We describe a patient with recurrent appendicitis after previous appendectomy and review the pertinent literature regarding this diagnostic dilemma...